The Ensign Group, Inc.
Case Overview
60 Days Left to Seek Lead Plaintiff
| Lead Plaintiff Deadline: | Lead Plaintiff Deadline:12/07/2026 |
| Status: | Status:Investigating |
| Company Name: | Company Name:The Ensign Group, Inc. |
| Court: | Court:Central District of California |
| Case Number: | Case Number:8:26cv02963 |
| Class Period: | Class Period:02/10/2022 - 06/18/2026 |
| Ticker: | Ticker:ENSG |
| Related Attorneys: | Lead Attorneys:Thomas W. Elrod |
| Related Practices: | Related Practices:Securities |
The lawsuit alleges that Ensign failed to disclose that: (i) Ensign’s business model depends on the systematic and widespread neglect of elderly people who live in its facilities, including those with needs for high levels of care; (ii) Ensign’s abuse and neglect includes not giving residents enough food, medical attention, or even basic toiletries as well as failing to respond to residents in clear distress, which has resulted in resident deaths; (iii) Ensign uses self-reporting measures as a way to cover up that it systematically neglects patients; (iv) Ensign defrauds Medicaid and Medicare by taking federal funds to help patients who need high levels of care, and then neglecting those same patients; (v) Ensign falsifies the number of hours that Certified Nursing Assistants spend with residents; (vi) Ensign engages in an illegal scheme to rent the licenses of Administrators who are not generally present at, nor actually managing, its facilities; and (vii) Ensign materially understated the reputational and litigation exposure that comes with a dangerous, abhorrent, and illegal business model.
On June 8, 2026, Hunterbrook Media LLC (“Hunterbrook”) published a report entitled “Ensign: The Nursing Home Empire Built on Fatal Neglect,” asserting that a five-month investigation by Hunterbrook revealed that “Ensign’s business model relies on delivering inadequate care to patients while gaming data on quality[.] Patients are dying.” The report also stated that Ensign “boomed in recent years by rolling up distressed homes, cutting high-skilled nursing staff, and gaming metrics” and “Ensign’s profits can be traced to providing less care than its patients need—and less care than it is meant to provide based on the tax dollars it receives from the government.” On this news, the price of Ensign shares declined by $13.88 per share, or approximately 8.15%, from $170.30 per share on June 5, 2026 to close at $156.42 per share on June 8, 2026.
Then, on June 11, 2026, Muddy Waters Research published a report entitled “Ensign: Deceiving the Government at Estimated ~20% of Facilities.” The report stated, “We conclude that Ensign engages in a systematic scheme at an estimated ~20% of Skilled Nursing Facilities (SNFs) to rent the licenses of Administrators who are not generally present at, nor actually managing the facilities… We believe this scheme, which could amount to fraud against states, Medicare, and Medicaid, is the pillar upon which Ensign’s acquisition strategy and margins is built.” On this news, the price of Ensign shares declined by $4.52 per share, or approximately 2.98%, from $151.65 on June 10, 2026 to close at $147.13 on June 11, 2026.
Finally, on June 18, 2026, Hunterbrook issued a follow-up report entitled “New: Patients Hungry in Ensign Facilities,” which stated that Ensign residents and caregivers had reached out to Hunterbrook following the publication of its first report to add “new, firsthand evidence of resident hunger, payroll falsification, understaffing, and staff licensing issues.” The article asserted that “staff who have worked at Ensign’s facilities have flooded Hunterbrook’s inbox with harrowing accounts of conditions inside those facilities. The company, meanwhile has expanded its stock repurchase authorization to $100 million.” On this news, the price of Ensign shares declined by $2.19 per share, or approximately 1.4%, from $155.84 per share on June 17, 2026 to close at $153.65 per share on June 18, 2026.
On June 8, 2026, Hunterbrook Media LLC (“Hunterbrook”) published a report entitled “Ensign: The Nursing Home Empire Built on Fatal Neglect,” asserting that a five-month investigation by Hunterbrook revealed that “Ensign’s business model relies on delivering inadequate care to patients while gaming data on quality[.] Patients are dying.” The report also stated that Ensign “boomed in recent years by rolling up distressed homes, cutting high-skilled nursing staff, and gaming metrics” and “Ensign’s profits can be traced to providing less care than its patients need—and less care than it is meant to provide based on the tax dollars it receives from the government.” On this news, the price of Ensign shares declined by $13.88 per share, or approximately 8.15%, from $170.30 per share on June 5, 2026 to close at $156.42 per share on June 8, 2026.
Then, on June 11, 2026, Muddy Waters Research published a report entitled “Ensign: Deceiving the Government at Estimated ~20% of Facilities.” The report stated, “We conclude that Ensign engages in a systematic scheme at an estimated ~20% of Skilled Nursing Facilities (SNFs) to rent the licenses of Administrators who are not generally present at, nor actually managing the facilities… We believe this scheme, which could amount to fraud against states, Medicare, and Medicaid, is the pillar upon which Ensign’s acquisition strategy and margins is built.” On this news, the price of Ensign shares declined by $4.52 per share, or approximately 2.98%, from $151.65 on June 10, 2026 to close at $147.13 on June 11, 2026.
Finally, on June 18, 2026, Hunterbrook issued a follow-up report entitled “New: Patients Hungry in Ensign Facilities,” which stated that Ensign residents and caregivers had reached out to Hunterbrook following the publication of its first report to add “new, firsthand evidence of resident hunger, payroll falsification, understaffing, and staff licensing issues.” The article asserted that “staff who have worked at Ensign’s facilities have flooded Hunterbrook’s inbox with harrowing accounts of conditions inside those facilities. The company, meanwhile has expanded its stock repurchase authorization to $100 million.” On this news, the price of Ensign shares declined by $2.19 per share, or approximately 1.4%, from $155.84 per share on June 17, 2026 to close at $153.65 per share on June 18, 2026.